Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.

Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.

Item
http://www.wikidata.org/entity/Q43122929
Posttransplant lymphoproliferative disease after pediatric solid organ transplantationPediatric heart transplantation-indications and outcomes in the current era.Long-term outcome for immune suppression and immune related lymphoproliferative disorder: prospective data from the United Kingdom Children's Leukaemia and Cancer Group registry 1994-2004.Persistent Epstein-Barr viral load in Epstein-Barr viral naïve pediatric heart transplant recipients: Risk of late-onset post-transplant lymphoproliferative disease.Rituximab is Indispensable for Pediatric Heart Transplant Recipients Developing Post Transplant Lymphoproliferative Disorders.Malignancies after pediatric kidney transplantation: more than PTLD?Role for immune monitoring to tailor induction prophylaxis in pediatric heart recipients.Heart transplantation for congenital heart disease in the first year of life.The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review.Rehospitalization after pediatric heart transplantation: Incidence, indications, and outcomes.Post-transplant lymphoproliferative disease is associated with early sternotomy and left ventricular hypoplasia during infancy: a population-based retrospective review.Successful treatment of systemic and central nervous system post-transplant lymphoproliferative disorder without the use of high-dose methotrexate or radiation.Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient.A 16-year multi-institutional study of the role of age and EBV status on PTLD incidence among pediatric heart transplant recipients.Cord blood T cells retain early differentiation phenotype suitable for immunotherapy after TCR gene transfer to confer EBV specificity.Posttransplant Lymphoproliferative Disorder after Cardiac Transplantation in Children: Life Threatening Complications Associated with Chemotherapy Combined with Rituximab
P2860

Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.

Item
http://www.wikidata.org/entity/Q43122929
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
@en
Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
@nl
type
label
Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
@en
Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
@nl
prefLabel
Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
@en
Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients.
@en
P2093
P304
P31
P356
10.1016/J.HEALUN.2010.01.013
P433
P478
P577
P698
P921